×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| MEDICAMEN BIOTECH LTD. | 389.19 | 16.37 | 384.49 | 1.21 | 475.0 | 50.1 |
| ALBERT DAVID LTD. | 926.03 | 79.38 | 705.66 | 13.91 | 460 | 73.1 |
| OXYGENTA PHARMACEUTICAL LIMITE | NA | NA | NA | NA | 456 |
Medicamen Biotech Ltd., with Security Code 531146, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37.1 | 40.5 | 42.7 | 44.2 | 45.0 | 41.5 | 42.8 | 41.1 | 26.0 | 38.4 |
| Expenses | 30.4 | 33.1 | 36.5 | 38.6 | 38.2 | 36.6 | 36.3 | 34.9 | 27.0 | 34.4 |
| Operating Profit | 6.8 | 7.4 | 6.2 | 5.6 | 6.8 | 4.9 | 6.5 | 6.2 | -1.0 | 4.0 |
| OPM % | 18.22% | 18.3% | 14.42% | 12.63% | 15.16% | 11.72% | 15.29% | 15.17% | -3.91% | 10.49% |
| Other Income | 0.3 | 0.4 | 0.6 | 0.8 | 0.5 | 0.6 | 0.3 | 0.1 | 5.2 | 0.5 |
| Interest | 0.9 | 1.0 | 0.9 | 0.6 | 1.9 | 0.7 | 1.0 | 0.7 | 0.6 | 0.6 |
| Depreciation | 1.6 | 1.7 | 1.8 | 1.8 | 1.8 | 1.7 | 2.6 | 2.2 | 0.5 | 1.8 |
| Profit before tax | 4.6 | 5.2 | 4.0 | 4.0 | 3.7 | 3.0 | 3.3 | 3.5 | 3.1 | 2.2 |
| Tax % | -12.9% | -14.3% | -24.7% | -31% | -16.7% | -25.1% | -30.3% | -27.5% | -19.8% | 24.6% |
| Net Profit | 4.0 | 4.4 | 3.0 | 2.8 | 3.1 | 2.3 | 2.3 | 2.5 | 2.4 | 1.6 |
| EPS in Rs | 3.25 | 3.49 | 2.38 | 2.19 | 2.45 | 1.78 | 1.78 | 1.98 | 0 | 1.21 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 35.6 | 38.7 | 41.9 | 43.5 | 46.5 | 47.3 | 43.0 | 44.7 | 45.1 | 29.6 |
| Expenses | 29.7 | 32.2 | 35.0 | 38.9 | 41.6 | 41.6 | 39.6 | 39.4 | 38.4 | 31.2 |
| Operating Profit | 5.9 | 6.5 | 7.0 | 4.6 | 4.9 | 5.8 | 3.4 | 5.3 | 6.7 | -1.6 |
| OPM % | 16.52% | 16.78% | 16.57% | 10.67% | 10.52% | 12.15% | 8% | 11.88% | 14.86% | -5.26% |
| Other Income | 0.6 | 0.3 | 0.4 | 0.6 | 0.8 | 0.6 | 0.6 | 0.3 | 0.1 | 5.2 |
| Interest | 0.7 | 0.9 | 1.0 | 0.9 | 0.6 | 1.9 | 0.7 | 1.0 | 0.8 | 0.7 |
| Depreciation | 1.6 | 1.6 | 1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 2.6 | 2.2 | 0.5 |
| Profit before tax | 4.2 | 4.4 | 4.7 | 2.5 | 3.3 | 2.7 | 1.6 | 2.0 | 3.9 | 2.5 |
| Tax % | -10.7% | -13.5% | -15.7% | -40.1% | -38% | -23.2% | 48.7% | -53.8% | 24.6% | -24.1% |
| Net Profit | 3.8 | 3.8 | 3.9 | 1.5 | 2.0 | 2.0 | 0.8 | 0.9 | 2.9 | 1.9 |
| EPS in Rs | 2.98 | 3.03 | 3.12 | 1.17 | 1.6 | 1.61 | 0.63 | 0.71 | 2.3 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 7% |
| 3 Years: | 16% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 65% |
| 5 Years: | 2% |
| 3 Years: | 2% |
| TTM: | -29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 12% |
| 3 Years: | -12% |
| 1 Year: | -18% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 8% |
| 3 Years: | 17% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -5% |
| 3 Years: | -8% |
| TTM: | -41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 12% |
| 3 Years: | -12% |
| 1 Year: | -18% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|